Document:

Form of Stock Option Agreement

  
 Exhibit 10.4

  
 NMT MEDICAL, INC. 
  
 NONSTATUTORY STOCK OPTION LETTER AGREEMENT 
  
 1996 STOCK OPTION PLAN FOR NON-EMPLOYEE DIRECTORS, AS AMENDED

  
 TO: [First Name] [Last Name] 
  
 NMT Medical, Inc., a Delaware corporation (the “Company”),
hereby grants to you a nonstatutory stock option to purchase <<Number>> shares of the Company’s common stock, $.001 par value, at an exercise price of <<Price>> per share (the “Option”) pursuant to the 1996
Stock Option Plan for Non-Employee Directors, as amended (the “Plan”). The date of grant of the option is <<Grant Date>>. This Option is not intended to constitute an incentive stock option as defined in Section 422A of the
Internal Revenue Code of 1986, as amended, and is subject to the terms and conditions of the Plan, which are incorporated into this Agreement by reference. 
  
 The terms of the Option are as set forth in the Plan and in this Agreement. The most important of the terms set forth in the Plan are summarized as
follows: 
  
 Term. The term of the Option is ten years from
date of grant, unless sooner terminated. 
  
 Exercise.
During your lifetime only you can exercise the Option. You may use the Notice of Exercise in the form attached to this Agreement when you exercise the Option. 
  

Payment for Shares. The Option may be exercised by the delivery of cash, bank certified or cashier’s check. 
  
 Termination. Upon termination of your service as a Director for any
reason, all outstanding options that have become vested as of the date of termination shall be exercisable in whole or in part for a period of one year from the date upon which you cease to be a Director. 
  
 Transfer of Option. The Option is not transferable except by will or
by the applicable laws of descent and distribution or pursuant to a qualified domestic relations order. 
  
 Vesting. The option shall vest <<Vesting Schedule>>. 
  
 You understand that, during any period in which the shares which may be acquired pursuant to your Option are subject to the
provisions of Section 16 of the Securities Exchange Act of 1934, as amended (and you yourself are also so subject), in order for your transactions under the Plan to qualify for the exemption from Section 16(b) provided by Rule 16b-3, a total of six
months must elapse between the grant of the Option and the sale of shares underlying the Option. 
  
 Please execute the Acceptance and Acknowledgement set forth below on the enclosed copy of this Agreement and return it to the undersigned. 
  

			
	 Very truly yours,

	
	 NMT Medical, Inc.

		
	 By:
	 	 
	 Name:
	 	 
	 Title:
	 	 

  

 ACCEPTANCE AND ACKNOWLEDGEMENT 
  

I, a resident of the State of
                     , accept the Option (dated <<Grant Date>>) described above granted under the NMT Medical, Inc. 1996
Stock Option Plan for Non-Employee Directors, as Amended, and acknowledge receipt of a copy of this Agreement, including a copy of the Plan. I have read and understand the Plan. 
  

			
		
	 Dated: 
	 	 

			
		
	 Taxpayer I.D. Number: 
	 	 

			
		
	 Signature: 
	 	 

  
 [First Name] [Last Name], <<Grant Date>>. 
  

 NOTICE OF EXERCISE 
  
 The undersigned, pursuant to a Nonstatutory Stock Option Letter Agreement (the “Agreement”) between the undersigned and NMT Medical, Inc. (the
“Company”), hereby irrevocably elects to exercise purchase rights represented by the Agreement, and to purchase thereunder shares (the “Shares”) of the Company’s common stock, $.001 par value (“Common Stock”),
covered by the Agreement and herewith makes payment in full therefor. 
  
 1. If the sale of the Shares and the resale thereof has not, prior to the date hereof, been registered pursuant to a registration statement filed and declared effective under the Securities Act of 1933, as amended (the “Act”), the
undersigned hereby agrees, represents, and warrants that: 
  
 (a) the undersigned is acquiring the Shares for his or her own account (and not for the account of others), for investment and not with a view to the distribution or resale thereof; 
  
 (b) By virtue of his or her position, the undersigned has
access to the same kind of information which would be available in a registration statement filed under the Act; 
  
 (c) the undersigned is a sophisticated investor; 
  

(d) the undersigned understands that he or she may not sell or otherwise dispose of the Shares in the absence of either (i) a
registration statement filed under the Act or (ii) an exemption from the registration provisions thereof; and 
  
 (e) The certificates representing the Shares may contain a legend to the effect of subsection (d) of this Section 1. 
  
 2. If the sale of the Shares and the resale thereof has been registered
pursuant to a registration statement filed and declared effective under the Act, the undersigned hereby represents and warrants that he or she has received the applicable prospectus and a copy of the most recent annual report, as well as all other
material sent to stockholders generally. 
  
 3. The undersigned
acknowledges that the number of shares of Common Stock subject to the Agreement is hereafter reduced by the number of shares of Common Stock represented by the Shares. 
  

			
	 Very truly yours,

		
	Name: 	 	 

			
		
	Social Security No.	 	 

			
		
	 Address:Amendment To Employment Agreement and Ted A. Fernandez

 Exhibit 10.1 
  
 AMENDMENT TO EMPLOYMENT AGREEMENT 
  
 AMENDMENT made effective the 10th day of November, 2004 to the Employment Agreement dated May 26, 1998 between
Answerthink, Inc. (formerly known as AnswerThink Consulting Group, Inc.) (the “Company”) and Ted A. Fernandez (the “Executive”). 
  
 1. Section 5(a) shall be amended and restated in its entirety to read and provide as follows: 
  
 (a) Base Salary. During the Employment Period, the Company
shall pay Executive an annual base salary (the “Base Salary”) which shall be at the rate of $495,192. The Base Salary shall be reviewed no less frequently than annually and may be increased at the discretion of the Board. If the
Executive’s Base Salary is increased, the increased amount shall be the Base Salary for the remainder of the Employment Period. Except as otherwise agreed in writing by the Executive, the Base Salary shall not be reduced from the amount
previously in effect during the Employment Period. The Base Salary shall be payable biweekly or in such other installments as shall be consistent with the Company’s payroll practice. 
  
 2. Section 9(a) shall be amended and restated in its entirety to read and provide as follows: 
  
 (a) Death. If the Executive’s employment is terminated
during the Employment Term as a result of the Executive’s death, (i) the Company shall pay the Executive’s estate, or as may be directed by the legal representatives of such estate, the Executive’s full Base Salary through the Date of
Termination and all other unpaid amounts, if any, to which the Executive is entitled as of the Date of Termination in connection with any fringe benefits or under any bonus or incentive compensation plan or program of the Company pursuant to Section
5(b) and (c) hereof, at the time such payments are due; (ii) the Executive’s rights with respect to stock options, shares of restricted stock and restricted stock units previously granted by the Company shall be fully vested and nonforfeitable
(and shares of stock shall be delivered to the Executive in satisfaction of restricted stock units) as of the Date of Termination; and (iii) all deferred and incentive compensation or bonus amounts awarded by the Company to the Executive and other
contingent or deferred compensation awards or grants made by the Company to the Executive, or otherwise made in connection with the Executive’s employment hereunder, shall become fully vested and nonforfeitable upon the Date of Termination. The
Company shall have no further obligations to the Executive under this Agreement. 
  

 1 

 3. Section 9(b) shall be amended and restated in its entirety to read and provide as follows: 

 
 (b) Disability. If the Company terminates the
Executive’s employment during the Employment Period because of the Executive’s disability pursuant to Section 8(a)(ii)(A) hereof, (i) the Company shall pay the Executive the Executive’s full Base Salary through the Date of Termination
and all other unpaid amounts, if any, to which the Executive is entitled as of the Date of Termination in connection with any fringe benefits or under any bonus incentive compensation plan or program of the Company pursuant to Sections 5(b) and (c)
hereof, at the time such payments are due; provided, that payments so made to the Executive during any period that the Executive is unable to perform all of the Executive’s duties hereunder by reason of illness, physical or mental illness or
other similar incapacity shall be reduced by the sum of the amounts, if any, payable to the Executive at or prior to the time of any such payment under disability plans of the Company and which amounts were not previously applied to reduce such
payment; (ii) the Executive’s rights with respect to stock options, shares of restricted stock and restricted stock units previously granted by the Company shall be fully vested and nonforfeitable (and shares of stock shall be delivered to the
Executive in satisfaction of restricted stock units) as of the Date of Termination; (iii) all deferred and incentive compensation or bonus amounts awarded by the Company to the Executive and other contingent or deferred compensation awards or grants
made by the Company to the Executive, or otherwise made in connection with the Executive’s employment hereunder, shall become fully vested and nonforfeitable upon the Date of Termination; and (iv) the Company shall pay the Executive an
aggregate amount equal to the sum of (A) Executive’s Base Salary and (B) Executive’s Bonus for the twelve month period immediately preceding the Date of Termination, payable in equal installments on the Company’s regular salary
payment dates (the “Severance Payments”) during the one-year period commencing on the Date of Termination (the “Initial Period”). In addition, the Company shall have the option, by delivering written notice to the Executive in
accordance with Section 11 hereof within 90 days after the Date of Termination, to extend the severance period to the second anniversary of the Date of Termination (the “Extended Period”). During the Extended Period, the Company will
continue to make Severance Payments at the same annual rate to the Executive. 
  

 2 

 4. Section 9(d) shall be amended and restated in its entirety to read and provide as follows: 

 
 (d) By the Company without Cause or by the Executive for
Good Reason. If the Company terminates the Executive’s employment during the Employment Period other than for Cause, disability or death pursuant to Section 8(a)(i) or (ii) hereof, or the Executive terminates his employment during the
Employment Period for Good Reason pursuant to Section 8(a)(iii) hereof, (i) the Company shall pay the Executive his full Base Salary through the Date of Termination and all other unpaid amounts, if any, to which the Executive is entitled as of the
Date of Termination in connection with any fringe benefits or under any bonus incentive compensation plan or program of the Company pursuant to Sections 5(b) and (c) hereof, at the time such payments are due, (ii) the Executive’s rights with
respect to stock options, shares of restricted stock and restricted stock units previously granted by the Company shall be fully vested and nonforfeitable (and shares of stock shall be delivered to the Executive in satisfaction of restricted stock
units) as of the Date of Termination; (iii) all deferred and incentive compensation or bonus amounts awarded by the Company to the Executive and other contingent or deferred compensation awards or grants made by the Company to the Executive, or
otherwise made in connection with the Executive’s employment hereunder, shall become fully vested and nonforfeitable upon the Date of Termination and (iv), subject to Section 9(e) hereof, during the Initial Period, the Company shall pay the
Executive an amount equal to the Severance Payments. In addition, the Company shall have the option, by delivering written notice to the Executive in accordance with Section 11 hereof within 90 days after the Date of Termination, to make additional
Severance payments through the end of the Extended Period. During the Extended Period, the Company will continue to make Severance Payments at the same annual rate to the Executive. 
  
 5. Section 9(f) shall be deleted in its entirety. 
  
 6. The definition of “Good Reason” in Section 21 shall be amended in its entirety to read and provide as follows:

  
 “Good Reason” means (i) the
Company’s failure to perform or observe any of the material terms or provisions of this Agreement, and the continued failure of the Company to cure such default within 30 days after written demand for performance has been given to the Company
by the Executive, which demand shall describe specifically the nature of such alleged failure to perform or observe such material 
  

 3 

 provisions; or (ii) the assignment to the Executive of any duties inconsistent with the Executive’s
status as Chief Executive Officer of the Company or any substantial adverse alteration in the nature or status of the Executive’s responsibilities. Executive’s continued employment shall not constitute consent to, or a waiver of rights
with respect to, any act or failure to act constituting Good Reason hereunder. 
  
 7. The definition of “Severance Payments” in Section 21 shall be amended and restated in its entirety to read and provide as follows: 
  
 “Severance Payments” is defined in Section 9(b) above. 
  
 8. A new Section 22 shall be added to read and provide as follows:

  
 22. Vesting and Transaction Bonus Upon a
Change of Control. In the event of a Change of Control during the Employment Period, and regardless of whether or not the Executive’s employment is terminated in connection with such Change of Control, (i) the Executive’s rights with
respect to stock options, shares of restricted stock and restricted stock units previously granted by the Company shall be fully vested and nonforfeitable (and shares of stock shall be delivered to the Executive in satisfaction of restricted stock
units); (ii) all deferred and incentive compensation or bonus amount awarded by the Company to the Executive and other contingent or deferred compensation awards or grants made by the Company to the Executive, or otherwise made in connection with
the Executive’s employment hereunder, shall become fully vested and nonforfeitable; and (iii) the Company shall pay the Executive an aggregate amount equal to two hundred percent (200%) of the sum of (A) Executive’s Base Salary and (B)
Executive’s Bonus for the twelve month period immediately preceding the Change of Control (the “Transaction Bonus”), payable in equal installments on the Company’s regular salary payment dates over a twenty-four month period,
with such payments commencing with the Company’s first regular salary payment date after the Change of Control occurs. Notwithstanding anything in this Agreement to the contrary, if the Executive receives the Transaction Bonus in accordance
with this Section 22, the Executive shall not be entitled to the Severance Payments that are described in Sections 9(b)(iv) and 9(d)(iv) upon the Executive’s termination of employment by reason of disability, the Company’s termination of
the Executive without Cause or the Executive’s termination of employment with Good Reason, respectively. 
  

 4 

 9. All other provisions of the Agreement shall remain in full force and effect. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement on
November 10, 2004. 
  

							
	 	 	 	 	Answerthink, Inc.
				
	 Attest:
	 	 	 	 	 	 
				
	 By:
	 	 /s/ Frank A. Zomerfeld

	 	 By:
	 	 /s/ John F. Brennan

	 	 	 	 	 Name:
	 	 John F. Brennan

	 	 	 	 	 Title:
	 	 Executive Vice President, Finance and Chief Financial Officer

			
	 	 	 	 	 Ted A. Fernandez

	 Attest:
	 	 	 	 
			
	 By:
	 	 /s/ Frank A. Zomerfeld

	 	 /s/ Ted A. Fernandez

  

 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]